Evidence map›Paper›PMID 38106672›Full record

ArticleHeliyon2023

Retraction notice to "Dobera glabra (Forssk.) Poir. (Salvadoraceae); Phenolic constituents of the aqueous leaves extract and evaluation of its anti-inflammatory, analgesic activities" [Heliyon

Mahmoud Emam, Passant E Moustafa, Ahmed Elkhateeb, Sameh R Hussein, Mona M Marzouk, Sahar S Abd El-Rahman, El-Sayed S Abdel-Hameed, Rehab F Abdel-Rahman

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Retraction of
    2021
5 · Who and what money

Authors and funding

8 authors.

Mahmoud EmamCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China.
Passant E MoustafaDepartment of Pharmacology, Medical Research Division, National Research Centre, Giza, Egypt.
Ahmed ElkhateebDepartment of Phytochemistry and Plant Systematics, National Research Centre, 33 El Bohouth St., Dokki, Giza, P. O. 12622, Egypt.
Sameh R HusseinDepartment of Phytochemistry and Plant Systematics, National Research Centre, 33 El Bohouth St., Dokki, Giza, P. O. 12622, Egypt.
Mona M MarzoukDepartment of Phytochemistry and Plant Systematics, National Research Centre, 33 El Bohouth St., Dokki, Giza, P. O. 12622, Egypt.
Sahar S Abd El-RahmanDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
El-Sayed S Abdel-HameedLaboratory of Medicinal Chemistry, Theodor Bilharz Research Institute, Giza, Egypt.
Rehab F Abdel-RahmanDepartment of Pharmacology, Medical Research Division, National Research Centre, Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This retracts the article DOI: 10.1016/j.heliyon.2021.e06205.].

Identifiers

PMID38106672
PMCPMC10722317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.